John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Klaviyo
KVYO
$5.18B
| $6.88M | 0.02% |
270,197
+70,391
| +35% | +$1.88M |
|
777
AtriCure
ATRC
$2.51B
| $6.88M | 0.02% |
226,179
+33,442
| +17% | +$1.12M |
|
778
Valley National Bancorp
VLY
$7.79B
| $6.88M | 0.02% |
+864,160
| New | +$7.7M |
|
779
Carrier Global
CARR
$49.4B
| $6.88M | 0.02% |
118,300
+85,000
| +255% | +$4.78M |
|
780
CF Industries
CF
$19.6B
| $6.87M | 0.02% |
82,566
-142,642
| -63% | -$11.4M |
|
781
Lear
LEA
$8.18B
| $6.84M | 0.02% |
47,224
+35,737
| +311% | +$4.89M |
|
782
iShares MSCI South Korea ETF
EWY
$27B
| $6.82M | 0.02% |
101,600
+29,600
| +41% | +$1.88M |
|
783
Arcos Dorados Holdings
ARCO
$1.7B
| $6.82M | 0.02% |
613,078
+298,113
| +95% | +$3.54M |
|
784
Tenable Holdings
TENB
$3.74B
| $6.81M | 0.02% |
137,835
+21,293
| +18% | +$1.01M |
|
785
Werner Enterprises
WERN
$2.26B
| $6.8M | 0.02% |
173,933
+2,980
| +2% | +$119K |
|
786
Credit Acceptance
CACC
$6.26B
| $6.79M | 0.02% |
12,311
+9,211
| +297% | +$5.05M |
|
|
787
Advanced Micro Devices
AMD
$746B
| $6.78M | 0.02% |
37,584
-1,376,058
| -97% | -$241M |
|
788
CALL
NRG Energy
NRG
$23.5B
| $6.77M | 0.02% |
+100,000
| New | +$5.61M |
|
789
Kura Sushi USA
KRUS
$603M
| $6.76M | 0.02% |
58,718
-22,430
| -28% | -$2.18M |
|
790
Reliance Steel & Aluminium
RS
$19.5B
| $6.74M | 0.02% |
20,160
+11,960
| +146% | +$3.64M |
|
791
AbCellera Biologics
ABCL
$3.44B
| $6.71M | 0.02% |
1,480,915
+411,677
| +39% | +$2.1M |
|
792
HubSpot
HUBS
$12.2B
| $6.7M | 0.02% |
10,700
-12,400
| -54% | -$7.45M |
|
|
DFTX
793
Definium Therapeutics
DFTX
$5.81B
| $6.7M | 0.02% |
712,238
+573,142
| +412% | +$3.27M |
|
794
Progress Software
PRGS
$1.78B
| $6.69M | 0.02% |
125,454
+39,596
| +46% | +$2.17M |
|
795
Mine Safety
MSA
$7.29B
| $6.66M | 0.02% |
34,418
+1,733
| +5% | +$305K |
|
|
SWI
796
DELISTED
SolarWinds Corporation Common Stock
SWI
| $6.66M | 0.02% |
527,908
+2,876
| +0.5% | +$35K |
|
797
Zegna
ZGN
$3.72B
| $6.64M | 0.02% |
453,307
+28,134
| +7% | +$364K |
|
|
HPP
798
Hudson Pacific Properties
HPP
$798M
| $6.64M | 0.02% |
+146,965
| New | +$7.75M |
|
|
CSGS
799
DELISTED
CSG Systems International
CSGS
| $6.63M | 0.02% |
128,637
+11,244
| +10% | +$584K |
|
800
Vertex
VERX
$2.22B
| $6.61M | 0.02% |
208,040
-53,672
| -21% | -$1.45M |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.